Coronado Biosciences Lands $3,989,940 New Funding Round

  • Feed Type
  • Date
    6/8/2010
  • Company Name
    Coronado Biosciences
  • Mailing Address
    45 Rockefeller Plaza New York, NY 10111
  • Company Description
    Coronado Biosciences is a clinical stage biopharmaceutical company focused on making cancer care better. How do we define better? We hope to make cancer care safer and more easily tolerated with improved outcomes.
  • Website
    http://www.CoronadoBioSciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,989,940
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Includes amounts receivable upon exercise of certain warrants. The warrants have not yet been exercised. SEC regulatory filing.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.